These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 28027535)

  • 1. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS; Cho CW
    Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D; Li W; Zhang Y; Zhang B
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
    Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
    J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Arch Pharm Res; 2017 Dec; 40(12):1420-1432. PubMed ID: 29027133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation, characterization of paclitaxel-loaded Pluronic P105 polymeric micelles and in vitro reversal of multidrug resistant tumor].
    Wang YZ; Fang XL; Li YJ; Zhang ZW; Han LM; Sha XY
    Yao Xue Xue Bao; 2008 Jun; 43(6):640-6. PubMed ID: 18822969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy.
    Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH
    J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
    Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N
    Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation.
    Zhu B; Zhang H; Yu L
    Biomed Pharmacother; 2017 Feb; 86():547-554. PubMed ID: 28024291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
    Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
    Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H
    Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation.
    Saadat E; Amini M; Khoshayand MR; Dinarvand R; Dorkoosh FA
    Int J Pharm; 2014 Nov; 475(1-2):163-73. PubMed ID: 25148729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.